Oct 1
|
Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
|
Oct 1
|
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
|
Sep 30
|
Moderna (MRNA) Rises Higher Than Market: Key Facts
|
Sep 30
|
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
|
Sep 29
|
Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed
|
Sep 28
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
Sep 26
|
Moderna blamed after children offered £1,500 to take part in Covid-19 trial
|
Sep 25
|
As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
|
Sep 25
|
Covid-19 vaccine patent legal battle heading to Court of Appeal
|
Sep 24
|
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
|
Aug 30
|
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
|
Aug 29
|
New COVID vaccines are here. What to know about the latest shots as summer surge continues
|
Aug 29
|
Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination
|
Aug 28
|
Moderna, Inc. (MRNA): Among The Best Medical AI Companies
|
Jul 29
|
5 Biotech Stocks to Bet On Bright Industry Prospects
|
Jul 29
|
Exploring Analyst Estimates for Moderna (MRNA) Q2 Earnings, Beyond Revenue and EPS
|
Jul 29
|
RSV vaccine makers vying for market share in second year of shots
|
Jul 26
|
Moderna (MRNA) Stock Before Q2 Earnings: To Buy or Not to Buy?
|
Jul 26
|
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
|
Jul 26
|
Moderna Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution
|